Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Reinvestment Rate
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Reinvestment Rate of 16.27x as of December 2023, reinvesting CN¥602.32 Million (capex CN¥70.15 Million plus investments CN¥-532.17 Million) from operating cash flow of CN¥37.03 Million. See Shandong Keyuan Pharmaceutical Co. Ltd. (301281) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Reinvestment Rate (2021–2023)
Historical reinvestment intensity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Shandong Keyuan Pharmaceutical Co. Ltd. generate cash.
Annual Cash Flow Reinvestment Rate for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2023)
Year-by-year capital reinvestment analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. See 301281 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.27x | CN¥602.32 Million | CN¥37.03 Million | CN¥70.15 Million | ▲ +5958.1% |
| 2022 | 0.27x | CN¥31.11 Million | CN¥115.86 Million | CN¥31.11 Million | ▼ -30.8% |
| 2021 | 0.39x | CN¥20.19 Million | CN¥52.02 Million | CN¥20.19 Million | — |